ADAM10 and neoplasm: We therefore used a genetic knockout of ADAM10, from U251 GBM cells by CRISPR/Cas9, to investigate the resulting changes in protein shedding, protein expression, the proliferation of cells in vitro, and tumour xenografts in mice.